Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

What Can Korean Pharma Do Right To Build R&D, Alliances?

This article was originally published in PharmAsia News

Executive Summary

What is an ideal R&D business model for the South Korean pharma industry and what are some of the key factors that could lead to successful novel research? At a recent meeting in Seoul, executives from leading domestic pharma companies including Yuhan and Hanmi shared their views and experience on how to develop valuable assets and seal successful international licensing deals.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register